VGLL1 drives therapy resistance in estrogen receptor positive breast cancer [RNA-Seq 1]. VGLL1 drives therapy resistance in estrogen receptor positive breast cancer [RNA-Seq 1]
收藏NIAID Data Ecosystem2026-03-14 收录
官方服务：
资源简介：
To investigate if the drug verteporfin can inhibit VGLL1 co-transcriptional activity in Fulvestrant resistant breast cancer cells. Overall design: Comparative gene expression profiling analysis of RNA-seq data for FULVR cells treated with vertepotfin (2µM, 24 h) or vehicle (4 replicates per treatment)
创建时间：
2022-10-25
